Clinical trial
Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases
NCT07235111 is registered in ClinicalTrials.gov with Ospedale Policlinico San Martino as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases
- Lead sponsor
- Ospedale Policlinico San Martino
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 28, 2025
- Completion date
- September 17, 2039
- Enrollment
- 1,200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
als (amyotrophic lateral sclerosis), alzheimer disease, ftd, mci, parkinson disease, young-onset dementia